| Business Summary | | Quidel
Corporation
develops,
manufactures
and
markets
point-of-care
(POC)
rapid
diagnostic
tests
for
the
detection
and
management
of
a
variety
of
medical
conditions
and
illnesses.
These
products
provide
healthcare
professionals
and
consumers
with
accurate
and
cost-effective
diagnostic
information
at
the
POC.
The
Company's
products
are
sold
to
professionals
for
use
in
physician's
offices,
hospitals,
clinical
laboratories
and
wellness
screening
centers.
The
Company
also
manufactures
a
line
of
products
sold
to
consumers
through
distribution
partners
and
organizations
that
provide
store-branded
products.
Its
products
are
substantially
focused
on
women
and
family
health
in
areas
such
as
reproduction,
infectious
diseases,
general
health
screening
and
diseases
associated
with
the
elderly. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Quidel
develops,
manufactures,
and
markets
rapid
immunodiagnostic
products
which
provide
diagnoses
in
the
areas
of
reproductive
and
women's
health,
infectious
diseases,
allergies,
and
autoimmune
disorders.
For
the
six
months
ended
6/30/01,
revenues
decreased
8%
to
$35.1
million.
Net
loss
before
acct.
change
totalled
$449
thousand
vs.
income
of
$864
thousand.
Results
reflect
decreased
unit
sales,
and
$550
thousand
in
restructuring
charges. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Andre De Bruin, 53 Chairman | $295K | S. Wayne Kay Pres,
CEO | -- | Paul Landers CFO, VP | -- | Linda Haelewyn Sr.
VP, Global Commercial Operations | -- | Mark Paiz, 38 Sr.
VP, Product Devel. and Supply Operations | 160K | Dollar
amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|